Nicholas Company Inc. lowered its position in shares of GSK plc (NYSE:GSK – Free Report) by 20.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 161,440 shares of the pharmaceutical company’s stock after selling 42,215 shares during the quarter. Nicholas Company Inc.’s […]